ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,495Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 1006

$1.08M Total Retail Price of All Prescriptions

Rank: 34 out of 1006

458 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 4,040 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$114 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
CRESTOR 320 88 1 18
SIMVASTATIN 232 151 2 1
LEVOTHYROXINE SODIUM 224 129 3 2
LISINOPRIL 222 107 4 3
ATORVASTATIN CALCIUM 219 110 5 5
OXYCODONE HCL 215 67 S2 6 54
METFORMIN HCL 181 90 7 10
FUROSEMIDE 178 104 8 6
METOPROLOL TARTRATE 153 104 9 7
HYDROCODONE-ACETAMINOPHEN 148 12 S3 10 25
OMEPRAZOLE 140 74 11 9
NEXIUM 135 81 12 28
METOPROLOL SUCCINATE 126 81 13 12
SINGULAIR 124 27 14 82
ZETIA 122 61 15 51
ACTOS 122 61 15 89
SPIRIVA 118 29 17 48
ZOLPIDEM TARTRATE 114 43 18 14
LYRICA 110 18 19 115
DEXILANT 106 22 20 142
TRAZODONE HCL 101 64 21 21
LOSARTAN POTASSIUM 98 70 22 22
AMLODIPINE BESYLATE 94 40 23 4
OXYCONTIN 94 23 S2 23 98
MELOXICAM 90 31 25 67
OXYCODONE-ACETAMINOPHEN 89 29 S2 26 57
ADVAIR DISKUS 88 25 27 37
KOMBIGLYZE XR 86 27 28 319
JANUVIA 86 54 28 49
TRAMADOL HCL 82 11 30 35
TIZANIDINE HCL 79 21 31 179
GABAPENTIN 76 40 32 20
CYMBALTA 75 17 33 41
FENTANYL 67 22 S2 34 74
PROAIR HFA 66 0 35 64
LIPITOR 63 35 36 47
ALLOPURINOL 60 47 37 31
SYNTHROID 57 19 38 42
MONTELUKAST SODIUM 57 13 38 125
CARVEDILOL 57 39 38 36
COMBIVENT 56 16 41 200
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 24 42 38
OXYCODONE HCL-ACETAMINOPHEN 54 16 S2 42 138
AMLODIPINE BESYLATE-BENAZEPRIL 54 33 42 77
CARISOPRODOL 53 0 R 45 172
LOVAZA 53 0 45 157
RANITIDINE HCL 52 28 47 63
ATENOLOL 51 30 48 13
LANTUS SOLOSTAR 50 34 49 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.